A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Author: Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

Publisher: Springer Publishing Company

ISSN: 0925-5710

Source: International Journal of Hematology, Vol.98, Iss.2, 2013-08, pp. : 164-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content